SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sequent Scientific - Quaterly Results

14 Aug 2024 Evaluate
The sales for the June 2024 quarter moved up 42.68% to Rs. 576.70 millions as compared to Rs. 404.20 millions during the corresponding quarter last year.The Total Profit for the quarter ended June 2024 of Rs. 45.00 millions grew from Rs.-68.00 millionsOperating profit surged to 88.60 millions from the corresponding previous quarter of 6.30 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 576.70 404.20 42.68 576.70 404.20 42.68 1685.18 2226.85 -24.32
Other Income 108.40 97.00 11.75 108.40 97.00 11.75 459.80 282.42 62.81
PBIDT 88.60 6.30 1306.35 88.60 6.30 1306.35 193.16 18.82 926.35
Interest 8.10 9.80 -17.35 8.10 9.80 -17.35 43.61 25.13 73.54
PBDT 80.50 -66.00 -221.97 80.50 -66.00 -221.97 87.01 -6.31 -1478.92
Depreciation 20.00 24.30 -17.70 20.00 24.30 -17.70 89.40 91.15 -1.92
PBT 60.50 -90.30 -167.00 60.50 -90.30 -167.00 -2.39 -97.46 -97.55
TAX 15.50 -22.30 -169.51 15.50 -22.30 -169.51 -8.61 -36.66 -76.51
Deferred Tax 5.80 -7.30 -179.45 5.80 -7.30 -179.45 -13.20 -30.94 -57.34
PAT 45.00 -68.00 -166.18 45.00 -68.00 -166.18 6.22 -60.80 -110.23
Equity 499.00 498.90 0.02 499.00 498.90 0.02 498.86 498.86 0.00
PBIDTM(%) 15.36 1.56 885.71 15.36 1.56 885.71 11.46 0.85 1256.32

Viyash Scientific Share Price

208.35 1.05 (0.51%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×